Dataset v2026-08-31 59 providers tracked 72% of prices verified within 7 days Every price carries a source, a date and a grade. How we verify

Ro GLP-1 pricing

As of August 31, 2026:

Ro does not publish a compounded injectable price; its published pricing is tirzepatide as a brand-name pen at $299 per month at the starting dose, rising to $449 at higher doses (verified August 25, 2026, grade B). Full terms and modeled annual costs are in the table below.

Provider ID
prv_ro
Canonical name
Ro
Also known as
Official domain
ro.co
Provider type
insurance first
Pricing model
insurance first
Membership fee
not published
Dose pricing
increasing
Shipping
included
Consultation
included
Price lock stated
not stated
Commitment
month-to-month membership
Cancellation
Cancel anytime
Pharmacies (provider-stated)
LillyDirect (Zepbound vials), NovoCare Pharmacy (Wegovy)
Pharmacy classification (provider-stated)
brand
States served
all-50
Affiliate relationship with this site
none recorded
Record last verified
August 25, 2026

Every published plan

Ro: every plan with a published or reported price. Unpriced protocols are omitted rather than guessed.
MedicationFormulationPlanAdvertised /moMaintenance-dose /moAll-in /mo12-month all-inGradeVerifiedSource
tirzepatidebrand-name penmonth-to-month$299$449$449$4,977Bro.co

Notes from verification

  • tirzepatide, month-to-month: Brand-name Zepbound at Lilly's conditional Self Pay Journey prices: $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5 to 15 mg, plus Ro's Body membership ($39 the first month, then commitment-dependent; about $74 per month on an annual plan and higher month-to-month, amount not fixed publicly).

Listed without a price

  • semaglutide, brand pen: Brand Wegovy: promotional low-dose pricing may apply to initial fills; ongoing self-pay pricing is dose and offer dependent and is billed separately from the membership.

Price history

No changes recorded yet for Ro; history starts with dataset v2026-08-31. Every future change lands here and in the site-wide log.

Full price-history page

Regulatory records

None on file for Ro. Per the regulatory policy, only events matched to a primary source are published.

First-party price sources

Data

This record as JSON: /providers/ro/data.json · API: /api/v1/providers/ro.json · Cite as “GLP-1 Price Compare, Ro Pricing, verified August 25, 2026”. Wrong? File a correction.

Questions this page answers

How much does Ro cost?

Ro does not publish a compounded injectable price; its published pricing is tirzepatide as a brand-name pen at $299 per month at the starting dose, rising to $449 at higher doses (verified August 25, 2026, grade B). Full terms and modeled annual costs are in the table below.